Baird Medical Investment (NASDAQ:BDMD) Trading Down 2.5% – Time to Sell?

Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s stock price traded down 2.5% during trading on Thursday . The stock traded as low as $1.10 and last traded at $1.16. 78,671 shares were traded during trading, an increase of 52% from the average session volume of 51,711 shares. The stock had previously closed at $1.19.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Baird Medical Investment in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Baird Medical Investment Stock Performance

The business’s 50 day moving average price is $1.11 and its 200 day moving average price is $1.53.

Hedge Funds Weigh In On Baird Medical Investment

A number of large investors have recently bought and sold shares of BDMD. Geode Capital Management LLC boosted its position in Baird Medical Investment by 59.7% during the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock worth $93,000 after purchasing an additional 9,511 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Baird Medical Investment during the 2nd quarter worth approximately $142,000. Finally, Citadel Advisors LLC purchased a new position in shares of Baird Medical Investment during the 3rd quarter valued at approximately $99,000. Institutional investors and hedge funds own 19.78% of the company’s stock.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.